Exposure-Response Analysis of Nivolumab in Patients With Previously Treated or Untreated Advanced Melanoma
Author:
Affiliation:
1. Bristol-Myers Squibb; Princeton NJ USA
Funder
Bristol-Myers Squibb
Publisher
Wiley
Subject
Pharmacology (medical),Pharmacology
Reference26 articles.
1. In vitro characterization of the anti-PD-1 antibody nivolumab, BMS-936558, and in vivo toxicology in non-human primates;Wang;Cancer Immunol Res,2014
2. Nivolumab in previously untreated melanoma without BRAF mutation;Robert;N Engl J Med,2015
3. Combined nivolumab and ipilimumab or monotherapy in untreated melanoma;Larkin;N Engl J Med,2015
4. Nivolumab versus docetaxel in advanced squamous-cell non-small-cell lung cancer;Brahmer;N Engl J Med,2015
5. Nivolumab versus docetaxel in advanced nonsquamous non-small-cell lung cancer;Borghaei;N Engl J Med,2015
Cited by 27 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Confounding mitigation for the exposure‐response relationship of bevacizumab in colorectal cancer patients;British Journal of Clinical Pharmacology;2023-12-29
2. Antibody Drug Clearance: An Underexplored Marker of Outcomes with Checkpoint Inhibitors;Clinical Cancer Research;2023-12-13
3. Pediatric model‐based dose optimization using a pooled exposure–response safety analysis for nivolumab and nivolumab plus ipilimumab combination in melanoma;CPT: Pharmacometrics & Systems Pharmacology;2023-11-06
4. Time-Dependent Pharmacokinetics of Immune Checkpoint Inhibitors and their Implications and Considerations for Exposure–Response Analysis;Current Pharmacology Reports;2023-11-03
5. Real‐World nivolumab dosing patterns and safety outcomes in patients receiving adjuvant therapy for melanoma;Cancer Medicine;2022-07-25
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3